Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STAR COMBO PHARMA LIMITED Capital/Financing Update 2018

Aug 8, 2018

65746_rns_2018-08-08_7b63e612-3ec5-4329-af72-18331e0ff0a9.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [118 x 53] intentionally omitted <==

STAR COMBO PHARMA LTD ABN 38 6157 283 75 171 -177 Woodpark Rd Smithfield NSW 2164 P: +61 2 9756 6555 [email protected]

9 August 2018

ASX Announcement – Issue of 3,960,171 ordinary shares


The Company is pleased to advise it has resolved to issue 3,960,171 ordinary shares following the exercise of 3,960,171 options by Richlink Capital Pty Ltd and the subscription of $1.8 million which has been received by the Company.

The Company welcomes the exercise by Richlink Capital Pty Ltd whose shareholding of the Company has now increased to 8% of the capital of the Company.

For further information: Su Zhang CEO Star Combo Pharma Limited +61 2 9756 6555 [email protected]

Page 1